data_2gt6_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2gt6 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 10.3 m . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.113 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -167.17 157.38 11.19 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.563 1.545 . . . . 0.0 109.792 -174.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . 1.493 ' CB ' ' HB ' ' A' ' 131' ' ' THR . 81.2 p -140.29 128.81 22.81 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.095 1.358 . . . . 0.0 108.105 170.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -87.19 47.65 3.7 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-O 118.813 -0.993 . . . . 0.0 112.88 -178.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -175.87 134.05 0.44 Allowed Pre-proline 0 N--CA 1.477 0.921 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -82.02 -170.41 0.95 Allowed 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 123.618 2.879 . . . . 0.0 109.473 154.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 94.9 mt -132.12 119.1 20.49 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.156 1.382 . . . . 0.0 108.287 164.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 93.8 mt -141.94 157.52 44.87 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.959 2.103 . . . . 0.0 108.224 -174.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 61.05 -126.1 39.72 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -163.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 175.56 109.68 0.24 Allowed Glycine 0 CA--C 1.534 1.229 0 CA-C-O 118.561 -1.133 . . . . 0.0 112.926 174.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -76.68 149.93 30.59 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.957 2.438 . . . . 0.0 109.714 167.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -154.62 177.55 11.09 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 122.108 0.956 . . . . 0.0 113.102 -172.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 62.4 m -132.72 126.45 32.54 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 125.485 1.514 . . . . 0.0 108.132 157.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.2 mp -147.21 151.28 36.46 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.885 1.274 . . . . 0.0 112.145 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 80.4 m -89.02 139.54 30.35 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.341 1.457 . . . . 0.0 109.836 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 45.1 p -89.69 156.85 18.28 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 122.584 1.183 . . . . 0.0 111.911 178.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -53.69 -25.83 20.08 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 127.291 2.236 . . . . 0.0 114.093 165.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 27.8 m -74.69 -46.08 40.14 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.626 1.571 . . . . 0.0 110.543 171.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 126.33 5.84 5.94 Favored Glycine 0 N--CA 1.476 1.355 0 C-N-CA 125.331 1.443 . . . . 0.0 115.885 175.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -99.09 155.73 17.3 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.056 1.342 . . . . 0.0 110.067 173.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -118.63 99.12 6.59 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.336 1.055 . . . . 0.0 111.318 -162.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.5 mmmt -93.27 166.77 12.15 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.499 1.12 . . . . 0.0 113.676 -169.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 32.8 p -112.25 -174.67 2.51 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 128.839 2.856 . . . . 0.0 108.364 164.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -70.99 -29.9 66.0 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 119.016 0.825 . . . . 0.0 111.086 165.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.78 -27.43 63.91 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.157 0.983 . . . . 0.0 113.524 -169.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -61.22 -33.71 73.93 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.095 0.958 . . . . 0.0 111.92 173.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -89.63 -1.25 57.96 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -176.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.7 tt -66.98 115.71 7.0 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.145 -0.972 . . . . 0.0 110.71 -175.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 140.32 -10.81 3.01 Favored Glycine 0 N--CA 1.472 1.089 0 N-CA-C 115.053 0.781 . . . . 0.0 115.053 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -127.0 167.86 15.33 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 118.306 1.053 . . . . 0.0 109.206 167.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -71.98 140.58 49.18 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.968 -0.457 . . . . 0.0 109.992 170.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 25.8 mt -122.97 135.96 54.68 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.96 0.904 . . . . 0.0 110.6 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 84.1 mt -99.88 115.18 29.02 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.415 1.086 . . . . 0.0 108.143 166.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 40.6 mt -117.16 111.55 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -173.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -129.35 146.69 51.19 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.715 1.206 . . . . 0.0 112.049 -172.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -112.05 107.61 16.62 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.82 1.248 . . . . 0.0 110.259 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -131.61 167.17 22.74 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.257 1.408 . . . . 0.0 115.291 -171.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -127.46 111.93 14.39 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.038 1.335 . . . . 0.0 110.041 -161.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 43.6 m -53.79 -30.51 45.1 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 121.148 -0.97 . . . . 0.0 113.085 -177.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -84.07 -2.15 56.17 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.922 1.689 . . . . 0.0 115.016 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.12 152.63 21.25 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 121.072 1.76 . . . . 0.0 113.205 175.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -78.49 -130.04 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 123.627 2.885 . . . . 0.0 107.242 159.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -64.99 -18.87 65.65 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.583 1.553 . . . . 0.0 114.123 -174.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 49.1 t -65.93 -65.12 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.64 1.176 . . . . 0.0 112.001 -160.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 1.7 m -52.49 -51.19 75.22 Favored Pre-proline 0 CA--C 1.545 0.785 0 CA-C-O 117.433 -1.27 . . . . 0.0 114.19 170.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -63.67 -24.9 69.12 Favored 'Trans proline' 0 C--N 1.352 0.747 0 CA-C-N 121.228 1.474 . . . . 0.0 114.24 -176.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.43 ' CD ' ' HZ3' ' A' ' 179' ' ' LYS . 9.3 tm-20 -70.01 -33.76 72.44 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 120.573 1.533 . . . . 0.0 112.025 173.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.528 ' CD ' ' HZ2' ' A' ' 179' ' ' LYS . 73.0 mm-40 -76.23 -32.59 58.99 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 119.941 -1.724 . . . . 0.0 112.673 166.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.35 -41.01 98.82 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.855 1.262 . . . . 0.0 111.05 177.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -55.27 -55.98 25.19 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.721 1.608 . . . . 0.0 111.409 170.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.528 ' HZ2' ' CD ' ' A' ' 176' ' ' GLU . 32.9 mttp -53.02 -46.8 68.57 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.188 -0.945 . . . . 0.0 110.963 174.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 23.8 ttm -59.82 -44.8 93.85 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.044 1.337 . . . . 0.0 112.594 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 11.6 mm -67.63 -51.61 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 119.744 1.156 . . . . 0.0 109.544 177.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -66.06 -29.41 69.75 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.214 0.461 . . . . 0.0 111.425 -173.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 18.2 t -69.99 -37.49 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.178 0.991 . . . . 0.0 111.934 174.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 68.0 t -69.04 -41.53 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 119.784 1.175 . . . . 0.0 111.185 175.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -59.59 -46.96 87.41 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.04 0.936 . . . . 0.0 111.86 173.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -57.14 -43.17 82.19 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.502 1.521 . . . . 0.0 112.262 173.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.3 mm -72.57 -34.0 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 O-C-N 120.964 -1.085 . . . . 0.0 112.271 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -68.17 -42.02 80.62 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.99 1.316 . . . . 0.0 111.476 170.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 10.7 t -64.59 -38.21 90.23 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.537 1.535 . . . . 0.0 110.984 176.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 8.0 mm -59.84 -19.13 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 O-C-N 120.491 -1.381 . . . . 0.0 112.647 167.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 98.2 m 74.17 -36.12 0.32 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 128.15 2.58 . . . . 0.0 113.892 162.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 1.8 m -99.68 -17.8 17.59 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.202 1.801 . . . . 0.0 113.2 -155.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 11.0 mp -74.57 155.46 87.36 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 124.569 1.148 . . . . 0.0 109.436 166.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.65 -56.48 0.26 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.023 1.815 . . . . 0.0 110.533 -168.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -174.32 158.2 2.88 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 128.778 2.831 . . . . 0.0 108.262 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 20.6 tp -126.86 99.85 5.92 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.845 1.658 . . . . 0.0 108.993 167.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.7 m -89.07 119.6 69.81 Favored Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 123.65 0.78 . . . . 0.0 110.095 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -91.05 124.61 0.92 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.395 2.73 . . . . 0.0 112.472 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 15.2 tp -117.44 94.4 4.54 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.499 1.92 . . . . 0.0 109.799 -171.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -83.02 117.44 22.82 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.765 0.826 . . . . 0.0 109.676 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 97.5 mt -102.15 117.92 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.64 1.176 . . . . 0.0 109.439 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 35.8 t -74.65 128.87 36.61 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 174.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 21.0 pt -105.46 15.2 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.397 1.479 . . . . 0.0 113.366 169.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -110.66 39.73 0.16 Allowed Pre-proline 0 CA--C 1.559 1.303 0 C-N-CA 124.329 1.051 . . . . 0.0 113.464 -176.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -75.24 31.94 0.37 Allowed 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 125.166 3.91 . . . . 0.0 113.532 -166.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -138.1 30.57 2.46 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.496 1.919 . . . . 0.0 110.446 -174.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 9.1 ptp85 168.39 -23.41 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 130.232 3.413 . . . . 0.0 112.16 -176.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -69.07 165.68 19.73 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.236 0.925 . . . . 0.0 112.206 175.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.9 m -153.79 135.25 14.25 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.916 0.886 . . . . 0.0 110.772 -176.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -54.32 -47.41 72.51 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.508 1.523 . . . . 0.0 112.557 -177.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -70.72 -21.55 62.54 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 173.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -74.86 -45.98 39.45 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 120.305 1.411 . . . . 0.0 111.176 173.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 28.0 mm -57.09 -36.86 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.758 0.823 . . . . 0.0 111.954 172.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -57.23 -32.95 67.05 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 174.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -77.11 -45.13 27.95 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.473 0.709 . . . . 0.0 111.466 172.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -52.67 -39.02 61.46 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 121.123 -0.986 . . . . 0.0 112.285 172.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 3.9 t -57.38 -65.86 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 126.373 1.869 . . . . 0.0 111.664 169.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? -55.08 -48.31 73.73 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.233 0.924 . . . . 0.0 112.886 -171.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.81 -26.81 62.55 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.029 1.332 . . . . 0.0 112.767 -170.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -84.38 -46.95 11.2 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.968 0.804 . . . . 0.0 111.696 166.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 13.4 t 174.67 132.46 0.13 Allowed Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 126.749 2.02 . . . . 0.0 109.971 166.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -66.47 -6.47 15.23 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.226 2.617 . . . . 0.0 114.539 -175.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -73.44 -10.07 59.35 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 119.692 1.133 . . . . 0.0 112.294 167.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 20.3 tp -68.01 129.34 39.63 Favored 'General case' 0 C--N 1.342 0.28 0 O-C-N 120.823 -1.173 . . . . 0.0 110.326 172.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 26.6 t -97.28 118.57 43.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 168.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -100.86 124.07 8.13 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.4 mp -116.25 137.78 51.85 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.037 1.335 . . . . 0.0 110.636 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 59.3 p -139.19 170.31 16.19 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 127.027 2.131 . . . . 0.0 108.901 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -166.04 -174.59 35.65 Favored Glycine 0 CA--C 1.516 0.145 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 169.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.9 t -67.49 162.94 22.12 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 160.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 23.4 ttm105 -44.11 -39.65 4.4 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.073 0.949 . . . . 0.0 112.995 175.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' GLU . . . . . 0.458 ' H ' ' CD ' ' A' ' 232' ' ' GLU . 17.5 mp0 -68.56 -34.58 76.08 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.61 1.564 . . . . 0.0 111.977 -174.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -73.0 -37.08 67.12 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.85 -1.156 . . . . 0.0 111.177 172.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 85.0 t -67.2 -29.26 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.426 1.09 . . . . 0.0 112.472 172.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -65.77 -60.29 3.04 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.524 1.057 . . . . 0.0 108.604 163.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -46.37 -56.36 5.98 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.006 0.821 . . . . 0.0 112.584 -175.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 8.9 p -73.85 -35.49 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 119.5 1.046 . . . . 0.0 112.929 -172.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -73.13 -30.66 63.77 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.538 -0.726 . . . . 0.0 112.201 178.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -80.22 -36.98 33.98 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.552 1.941 . . . . 0.0 111.286 178.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -64.59 -52.48 57.36 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.073 0.949 . . . . 0.0 112.164 169.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -75.41 -5.97 47.66 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 175.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 54.72 53.55 10.41 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.429 1.892 . . . . 0.0 112.553 176.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 2.7 m -110.68 126.61 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.373 1.069 . . . . 0.0 111.182 -177.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -71.32 140.56 50.31 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -148.95 158.94 44.56 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.292 1.837 . . . . 0.0 110.55 160.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 16.3 t -149.37 122.22 4.41 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 123.958 0.903 . . . . 0.0 111.181 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -81.48 152.04 17.61 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.295 2.663 . . . . 0.0 111.729 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -83.67 -177.99 51.79 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 123.838 0.733 . . . . 0.0 112.014 164.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -78.85 -173.8 2.02 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.332 2.688 . . . . 0.0 110.395 172.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' LYS . . . . . 0.497 ' HZ2' ' CD ' ' A' ' 254' ' ' GLU . 6.6 mmpt? -66.78 126.56 29.4 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 154.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -150.05 158.72 44.45 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -170.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 60.29 -42.93 0.1 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 131.275 3.83 . . . . 0.0 114.979 -171.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -165.6 -56.58 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 127.096 2.159 . . . . 0.0 109.964 175.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' GLU . . . . . 0.497 ' CD ' ' HZ2' ' A' ' 250' ' ' LYS . 23.0 tp10 -154.38 12.41 0.41 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.92 1.688 . . . . 0.0 112.029 -175.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -80.22 175.49 10.6 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 119.127 -2.233 . . . . 0.0 111.391 170.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -176.37 83.69 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.994 2.518 . . . . 0.0 106.781 -164.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 8.7 tp -73.79 164.27 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.89 1.676 . . . . 0.0 111.039 -176.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 78.0 t -141.8 134.35 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 170.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -97.3 158.38 15.49 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.89 1.676 . . . . 0.0 110.261 166.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -162.9 144.66 10.14 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.597 1.159 . . . . 0.0 113.391 -166.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 6.4 t -65.8 -5.39 8.76 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 116.615 2.08 . . . . 0.0 116.615 -172.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . 1.568 ' CG2' HG23 ' A' ' 262' ' ' ILE . 4.9 mt 34.81 73.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 126.624 1.97 . . . . 0.0 114.911 -172.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 91.7 mt -120.09 131.68 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 O-C-N 121.471 -0.768 . . . . 0.0 109.332 173.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 61.3 mtp -99.79 113.57 26.16 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.79 1.636 . . . . 0.0 108.138 156.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -79.5 138.27 37.49 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 120.461 -1.4 . . . . 0.0 110.27 166.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 44.3 tp -95.43 112.31 24.04 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 168.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.61 140.84 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.158 0.983 . . . . 0.0 108.872 176.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -80.6 172.55 54.51 Favored Glycine 0 CA--C 1.541 1.663 0 C-N-CA 123.607 0.622 . . . . 0.0 113.412 176.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -70.1 66.4 1.97 Allowed 'Trans proline' 0 CA--C 1.541 0.834 1 C-N-CA 125.556 4.171 . . . . 0.0 110.416 168.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -173.47 -55.93 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.123 0.969 . . . . 0.0 110.322 -146.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 118.69 -26.48 7.6 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 117.905 -1.497 . . . . 0.0 114.614 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -97.19 163.14 13.04 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 119.909 1.854 . . . . 0.0 112.23 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.41 142.26 28.01 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -173.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 97.9 mt -126.92 -11.02 6.02 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.977 1.311 . . . . 0.0 113.923 -178.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -154.26 164.67 38.2 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.179 1.792 . . . . 0.0 109.141 169.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -140.0 119.16 12.77 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.82 0.848 . . . . 0.0 109.265 167.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -96.34 121.25 37.94 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -94.96 174.91 33.27 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 163.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -65.49 78.24 0.07 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.423 1.489 . . . . 0.0 109.93 169.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -170.59 -44.7 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.881 1.272 . . . . 0.0 113.427 -170.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -66.47 120.24 13.03 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.897 0.771 . . . . 0.0 109.398 170.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.88 147.6 53.03 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 173.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -39.32 -54.81 1.81 Allowed 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -168.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -67.18 -28.98 73.87 Favored Glycine 0 CA--C 1.535 1.332 0 CA-C-N 118.841 0.746 . . . . 0.0 114.177 -177.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -65.8 -25.47 67.25 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.706 1.253 . . . . 0.0 111.757 176.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 67.1 mt -66.95 -56.61 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.104 0.962 . . . . 0.0 109.649 176.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.01 -34.8 73.85 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.777 0.831 . . . . 0.0 112.776 174.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -61.91 -36.29 80.9 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.709 0.803 . . . . 0.0 112.785 174.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.37 -46.37 88.96 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.074 0.852 . . . . 0.0 112.776 164.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 58.2 mt -64.82 -39.15 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-N 120.06 1.3 . . . . 0.0 111.841 -176.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.96 -18.12 65.12 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.585 1.154 . . . . 0.0 113.978 173.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 93.9 m -85.28 -50.71 7.13 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.548 1.139 . . . . 0.0 110.335 174.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -67.35 -20.05 65.53 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.874 1.27 . . . . 0.0 113.028 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 13.1 tmm? -58.26 -29.69 65.98 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.288 1.035 . . . . 0.0 113.001 165.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -54.65 -48.8 94.33 Favored Pre-proline 0 CA--C 1.547 0.846 0 CA-C-N 120.566 1.53 . . . . 0.0 112.664 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -74.65 -54.01 0.1 OUTLIER 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.619 2.213 . . . . 0.0 112.268 167.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -94.98 73.66 3.47 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 123.67 1.7 . . . . 0.0 111.215 -171.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 47.7 ptt85 -90.55 123.36 34.15 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 117.004 2.224 . . . . 0.0 117.004 -153.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' LYS . . . . . 0.461 ' HG2' ' H ' ' A' ' 300' ' ' LYS . 11.7 ttpp 71.95 -141.84 0.05 OUTLIER 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 113.734 -1.575 . . . . 0.0 114.386 126.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' LYS . . . . . 0.461 ' H ' ' HG2' ' A' ' 299' ' ' LYS . 23.5 mttt -145.73 34.09 1.03 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 129.076 2.95 . . . . 0.0 107.898 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.487 1.404 0 C-N-CA 130.388 3.475 . . . . 0.0 111.112 -161.906 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 10.3 m . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.113 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -167.17 157.38 11.19 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.563 1.545 . . . . 0.0 109.792 -174.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 81.2 p -140.29 128.81 22.81 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.095 1.358 . . . . 0.0 108.105 170.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -87.19 47.65 3.7 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-O 118.813 -0.993 . . . . 0.0 112.88 -178.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -175.87 134.05 0.44 Allowed Pre-proline 0 N--CA 1.477 0.921 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -82.02 -170.41 0.95 Allowed 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 123.618 2.879 . . . . 0.0 109.473 154.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 94.9 mt -132.12 119.1 20.49 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.156 1.382 . . . . 0.0 108.287 164.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 93.8 mt -141.94 157.52 44.87 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.959 2.103 . . . . 0.0 108.224 -174.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 61.05 -126.1 39.72 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -163.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 175.56 109.68 0.24 Allowed Glycine 0 CA--C 1.534 1.229 0 CA-C-O 118.561 -1.133 . . . . 0.0 112.926 174.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -76.68 149.93 30.59 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.957 2.438 . . . . 0.0 109.714 167.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -154.62 177.55 11.09 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 122.108 0.956 . . . . 0.0 113.102 -172.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 62.4 m -132.72 126.45 32.54 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 125.485 1.514 . . . . 0.0 108.132 157.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.2 mp -147.21 151.28 36.46 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.885 1.274 . . . . 0.0 112.145 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 80.4 m -89.02 139.54 30.35 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.341 1.457 . . . . 0.0 109.836 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 45.1 p -89.69 156.85 18.28 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 122.584 1.183 . . . . 0.0 111.911 178.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -53.69 -25.83 20.08 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 127.291 2.236 . . . . 0.0 114.093 165.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 27.8 m -74.69 -46.08 40.14 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.626 1.571 . . . . 0.0 110.543 171.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 126.33 5.84 5.94 Favored Glycine 0 N--CA 1.476 1.355 0 C-N-CA 125.331 1.443 . . . . 0.0 115.885 175.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -99.09 155.73 17.3 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.056 1.342 . . . . 0.0 110.067 173.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -118.63 99.12 6.59 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.336 1.055 . . . . 0.0 111.318 -162.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.5 mmmt -93.27 166.77 12.15 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.499 1.12 . . . . 0.0 113.676 -169.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 32.8 p -112.25 -174.67 2.51 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 128.839 2.856 . . . . 0.0 108.364 164.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -70.99 -29.9 66.0 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 119.016 0.825 . . . . 0.0 111.086 165.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.78 -27.43 63.91 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.157 0.983 . . . . 0.0 113.524 -169.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -61.22 -33.71 73.93 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.095 0.958 . . . . 0.0 111.92 173.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -89.63 -1.25 57.96 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -176.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.7 tt -66.98 115.71 7.0 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.145 -0.972 . . . . 0.0 110.71 -175.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 140.32 -10.81 3.01 Favored Glycine 0 N--CA 1.472 1.089 0 N-CA-C 115.053 0.781 . . . . 0.0 115.053 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -127.0 167.86 15.33 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 118.306 1.053 . . . . 0.0 109.206 167.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -71.98 140.58 49.18 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.968 -0.457 . . . . 0.0 109.992 170.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 25.8 mt -122.97 135.96 54.68 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.96 0.904 . . . . 0.0 110.6 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 84.1 mt -99.88 115.18 29.02 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.415 1.086 . . . . 0.0 108.143 166.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 40.6 mt -117.16 111.55 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -173.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -129.35 146.69 51.19 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.715 1.206 . . . . 0.0 112.049 -172.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -112.05 107.61 16.62 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.82 1.248 . . . . 0.0 110.259 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -131.61 167.17 22.74 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.257 1.408 . . . . 0.0 115.291 -171.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -127.46 111.93 14.39 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.038 1.335 . . . . 0.0 110.041 -161.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 43.6 m -53.79 -30.51 45.1 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 121.148 -0.97 . . . . 0.0 113.085 -177.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -84.07 -2.15 56.17 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.922 1.689 . . . . 0.0 115.016 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.12 152.63 21.25 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 121.072 1.76 . . . . 0.0 113.205 175.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -78.49 -130.04 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 123.627 2.885 . . . . 0.0 107.242 159.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -64.99 -18.87 65.65 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.583 1.553 . . . . 0.0 114.123 -174.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 49.1 t -65.93 -65.12 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.64 1.176 . . . . 0.0 112.001 -160.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 1.7 m -52.49 -51.19 75.22 Favored Pre-proline 0 CA--C 1.545 0.785 0 CA-C-O 117.433 -1.27 . . . . 0.0 114.19 170.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -63.67 -24.9 69.12 Favored 'Trans proline' 0 C--N 1.352 0.747 0 CA-C-N 121.228 1.474 . . . . 0.0 114.24 -176.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -70.01 -33.76 72.44 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 120.573 1.533 . . . . 0.0 112.025 173.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.54 ' CD ' ' HZ3' ' A' ' 179' ' ' LYS . 73.0 mm-40 -76.23 -32.59 58.99 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 119.941 -1.724 . . . . 0.0 112.673 166.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.35 -41.01 98.82 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.855 1.262 . . . . 0.0 111.05 177.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -55.27 -55.98 25.19 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.721 1.608 . . . . 0.0 111.409 170.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.54 ' HZ3' ' CD ' ' A' ' 176' ' ' GLU . 32.9 mttp -53.02 -46.8 68.57 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.188 -0.945 . . . . 0.0 110.963 174.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 23.8 ttm -59.82 -44.8 93.85 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.044 1.337 . . . . 0.0 112.594 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 11.6 mm -67.63 -51.61 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 119.744 1.156 . . . . 0.0 109.544 177.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLN . . . . . 0.494 ' HB3' ' HE3' ' A' ' 283' ' ' LYS . 65.7 mt-30 -66.06 -29.41 69.75 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.214 0.461 . . . . 0.0 111.425 -173.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 18.2 t -69.99 -37.49 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.178 0.991 . . . . 0.0 111.934 174.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 68.0 t -69.04 -41.53 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 119.784 1.175 . . . . 0.0 111.185 175.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -59.59 -46.96 87.41 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.04 0.936 . . . . 0.0 111.86 173.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -57.14 -43.17 82.19 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.502 1.521 . . . . 0.0 112.262 173.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.3 mm -72.57 -34.0 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 O-C-N 120.964 -1.085 . . . . 0.0 112.271 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -68.17 -42.02 80.62 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.99 1.316 . . . . 0.0 111.476 170.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 10.7 t -64.59 -38.21 90.23 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.537 1.535 . . . . 0.0 110.984 176.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 8.0 mm -59.84 -19.13 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 O-C-N 120.491 -1.381 . . . . 0.0 112.647 167.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 98.2 m 74.17 -36.12 0.32 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 128.15 2.58 . . . . 0.0 113.892 162.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 1.8 m -99.68 -17.8 17.59 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.202 1.801 . . . . 0.0 113.2 -155.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 11.0 mp -74.57 155.46 87.36 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 124.569 1.148 . . . . 0.0 109.436 166.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.65 -56.48 0.26 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.023 1.815 . . . . 0.0 110.533 -168.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -174.32 158.2 2.88 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 128.778 2.831 . . . . 0.0 108.262 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 20.6 tp -126.86 99.85 5.92 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.845 1.658 . . . . 0.0 108.993 167.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.7 m -89.07 119.6 69.81 Favored Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 123.65 0.78 . . . . 0.0 110.095 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -91.05 124.61 0.92 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.395 2.73 . . . . 0.0 112.472 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 15.2 tp -117.44 94.4 4.54 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.499 1.92 . . . . 0.0 109.799 -171.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -83.02 117.44 22.82 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.765 0.826 . . . . 0.0 109.676 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 97.5 mt -102.15 117.92 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.64 1.176 . . . . 0.0 109.439 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 35.8 t -74.65 128.87 36.61 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 174.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 21.0 pt -105.46 15.2 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.397 1.479 . . . . 0.0 113.366 169.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -110.66 39.73 0.16 Allowed Pre-proline 0 CA--C 1.559 1.303 0 C-N-CA 124.329 1.051 . . . . 0.0 113.464 -176.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -75.24 31.94 0.37 Allowed 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 125.166 3.91 . . . . 0.0 113.532 -166.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -138.1 30.57 2.46 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.496 1.919 . . . . 0.0 110.446 -174.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 9.1 ptp85 168.39 -23.41 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 130.232 3.413 . . . . 0.0 112.16 -176.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -69.07 165.68 19.73 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.236 0.925 . . . . 0.0 112.206 175.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.9 m -153.79 135.25 14.25 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.916 0.886 . . . . 0.0 110.772 -176.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -54.32 -47.41 72.51 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.508 1.523 . . . . 0.0 112.557 -177.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -70.72 -21.55 62.54 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 173.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -74.86 -45.98 39.45 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 120.305 1.411 . . . . 0.0 111.176 173.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 28.0 mm -57.09 -36.86 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.758 0.823 . . . . 0.0 111.954 172.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -57.23 -32.95 67.05 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 174.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -77.11 -45.13 27.95 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.473 0.709 . . . . 0.0 111.466 172.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -52.67 -39.02 61.46 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 121.123 -0.986 . . . . 0.0 112.285 172.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 3.9 t -57.38 -65.86 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 126.373 1.869 . . . . 0.0 111.664 169.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? -55.08 -48.31 73.73 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.233 0.924 . . . . 0.0 112.886 -171.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.81 -26.81 62.55 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.029 1.332 . . . . 0.0 112.767 -170.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -84.38 -46.95 11.2 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.968 0.804 . . . . 0.0 111.696 166.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 13.4 t 174.67 132.46 0.13 Allowed Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 126.749 2.02 . . . . 0.0 109.971 166.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -66.47 -6.47 15.23 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.226 2.617 . . . . 0.0 114.539 -175.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -73.44 -10.07 59.35 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 119.692 1.133 . . . . 0.0 112.294 167.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 20.3 tp -68.01 129.34 39.63 Favored 'General case' 0 C--N 1.342 0.28 0 O-C-N 120.823 -1.173 . . . . 0.0 110.326 172.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 26.6 t -97.28 118.57 43.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 168.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -100.86 124.07 8.13 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.4 mp -116.25 137.78 51.85 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.037 1.335 . . . . 0.0 110.636 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 59.3 p -139.19 170.31 16.19 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 127.027 2.131 . . . . 0.0 108.901 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -166.04 -174.59 35.65 Favored Glycine 0 CA--C 1.516 0.145 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 169.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.9 t -67.49 162.94 22.12 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 160.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 23.4 ttm105 -44.11 -39.65 4.4 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.073 0.949 . . . . 0.0 112.995 175.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 17.5 mp0 -68.56 -34.58 76.08 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.61 1.564 . . . . 0.0 111.977 -174.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -73.0 -37.08 67.12 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.85 -1.156 . . . . 0.0 111.177 172.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 85.0 t -67.2 -29.26 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.426 1.09 . . . . 0.0 112.472 172.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -65.77 -60.29 3.04 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.524 1.057 . . . . 0.0 108.604 163.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -46.37 -56.36 5.98 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.006 0.821 . . . . 0.0 112.584 -175.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 8.9 p -73.85 -35.49 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 119.5 1.046 . . . . 0.0 112.929 -172.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -73.13 -30.66 63.77 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.538 -0.726 . . . . 0.0 112.201 178.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -80.22 -36.98 33.98 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.552 1.941 . . . . 0.0 111.286 178.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -64.59 -52.48 57.36 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.073 0.949 . . . . 0.0 112.164 169.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -75.41 -5.97 47.66 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 175.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 54.72 53.55 10.41 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.429 1.892 . . . . 0.0 112.553 176.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 2.7 m -110.68 126.61 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.373 1.069 . . . . 0.0 111.182 -177.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -71.32 140.56 50.31 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -148.95 158.94 44.56 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.292 1.837 . . . . 0.0 110.55 160.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 16.3 t -149.37 122.22 4.41 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 123.958 0.903 . . . . 0.0 111.181 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -81.48 152.04 17.61 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.295 2.663 . . . . 0.0 111.729 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -83.67 -177.99 51.79 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 123.838 0.733 . . . . 0.0 112.014 164.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -78.85 -173.8 2.02 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.332 2.688 . . . . 0.0 110.395 172.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' LYS . . . . . 0.452 ' HZ3' ' CD ' ' A' ' 254' ' ' GLU . 6.6 mmpt? -66.78 126.56 29.4 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 154.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -150.05 158.72 44.45 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -170.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 60.29 -42.93 0.1 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 131.275 3.83 . . . . 0.0 114.979 -171.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -165.6 -56.58 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 127.096 2.159 . . . . 0.0 109.964 175.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' GLU . . . . . 0.452 ' CD ' ' HZ3' ' A' ' 250' ' ' LYS . 23.0 tp10 -154.38 12.41 0.41 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.92 1.688 . . . . 0.0 112.029 -175.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -80.22 175.49 10.6 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 119.127 -2.233 . . . . 0.0 111.391 170.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -176.37 83.69 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.994 2.518 . . . . 0.0 106.781 -164.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 8.7 tp -73.79 164.27 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.89 1.676 . . . . 0.0 111.039 -176.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 78.0 t -141.8 134.35 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 170.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -97.3 158.38 15.49 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.89 1.676 . . . . 0.0 110.261 166.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -162.9 144.66 10.14 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.597 1.159 . . . . 0.0 113.391 -166.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 6.4 t -65.8 -5.39 8.76 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 116.615 2.08 . . . . 0.0 116.615 -172.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.838 ' O ' HG22 ' A' ' 262' ' ' ILE . 4.9 mt 34.81 73.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 126.624 1.97 . . . . 0.0 114.911 -172.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 91.7 mt -120.09 131.68 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 O-C-N 121.471 -0.768 . . . . 0.0 109.332 173.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 61.3 mtp -99.79 113.57 26.16 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.79 1.636 . . . . 0.0 108.138 156.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -79.5 138.27 37.49 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 120.461 -1.4 . . . . 0.0 110.27 166.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 44.3 tp -95.43 112.31 24.04 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 168.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.61 140.84 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.158 0.983 . . . . 0.0 108.872 176.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -80.6 172.55 54.51 Favored Glycine 0 CA--C 1.541 1.663 0 C-N-CA 123.607 0.622 . . . . 0.0 113.412 176.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -70.1 66.4 1.97 Allowed 'Trans proline' 0 CA--C 1.541 0.834 1 C-N-CA 125.556 4.171 . . . . 0.0 110.416 168.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -173.47 -55.93 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.123 0.969 . . . . 0.0 110.322 -146.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 118.69 -26.48 7.6 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 117.905 -1.497 . . . . 0.0 114.614 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -97.19 163.14 13.04 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 119.909 1.854 . . . . 0.0 112.23 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.41 142.26 28.01 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -173.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 97.9 mt -126.92 -11.02 6.02 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.977 1.311 . . . . 0.0 113.923 -178.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -154.26 164.67 38.2 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.179 1.792 . . . . 0.0 109.141 169.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -140.0 119.16 12.77 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.82 0.848 . . . . 0.0 109.265 167.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -96.34 121.25 37.94 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -94.96 174.91 33.27 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 163.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' GLN . . . . . 0.419 ' HB2' HG21 ' A' ' 262' ' ' ILE . 40.8 tt0 -65.49 78.24 0.07 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.423 1.489 . . . . 0.0 109.93 169.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -170.59 -44.7 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.881 1.272 . . . . 0.0 113.427 -170.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -66.47 120.24 13.03 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.897 0.771 . . . . 0.0 109.398 170.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.88 147.6 53.03 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 173.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 283' ' ' LYS . . . . . 0.494 ' HE3' ' HB3' ' A' ' 182' ' ' GLN . 12.9 tmtt? -39.32 -54.81 1.81 Allowed 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -168.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -67.18 -28.98 73.87 Favored Glycine 0 CA--C 1.535 1.332 0 CA-C-N 118.841 0.746 . . . . 0.0 114.177 -177.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -65.8 -25.47 67.25 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.706 1.253 . . . . 0.0 111.757 176.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 67.1 mt -66.95 -56.61 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.104 0.962 . . . . 0.0 109.649 176.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.01 -34.8 73.85 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.777 0.831 . . . . 0.0 112.776 174.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -61.91 -36.29 80.9 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.709 0.803 . . . . 0.0 112.785 174.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.37 -46.37 88.96 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.074 0.852 . . . . 0.0 112.776 164.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 58.2 mt -64.82 -39.15 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-N 120.06 1.3 . . . . 0.0 111.841 -176.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.96 -18.12 65.12 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.585 1.154 . . . . 0.0 113.978 173.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 93.9 m -85.28 -50.71 7.13 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.548 1.139 . . . . 0.0 110.335 174.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -67.35 -20.05 65.53 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.874 1.27 . . . . 0.0 113.028 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 13.1 tmm? -58.26 -29.69 65.98 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.288 1.035 . . . . 0.0 113.001 165.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -54.65 -48.8 94.33 Favored Pre-proline 0 CA--C 1.547 0.846 0 CA-C-N 120.566 1.53 . . . . 0.0 112.664 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -74.65 -54.01 0.1 OUTLIER 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.619 2.213 . . . . 0.0 112.268 167.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -94.98 73.66 3.47 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 123.67 1.7 . . . . 0.0 111.215 -171.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 47.7 ptt85 -90.55 123.36 34.15 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 117.004 2.224 . . . . 0.0 117.004 -153.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' LYS . . . . . 0.444 ' HG2' ' H ' ' A' ' 300' ' ' LYS . 11.7 ttpp 71.95 -141.84 0.05 OUTLIER 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 113.734 -1.575 . . . . 0.0 114.386 126.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 300' ' ' LYS . . . . . 0.444 ' H ' ' HG2' ' A' ' 299' ' ' LYS . 23.5 mttt -145.73 34.09 1.03 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 129.076 2.95 . . . . 0.0 107.898 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.487 1.404 0 C-N-CA 130.388 3.475 . . . . 0.0 111.112 -161.906 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 10.3 m . . . . . 0 N--CA 1.48 1.059 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.113 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -167.17 157.38 11.19 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.563 1.545 . . . . 0.0 109.792 -174.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 81.2 p -140.29 128.81 22.81 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.095 1.358 . . . . 0.0 108.105 170.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -87.19 47.65 3.7 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-O 118.813 -0.993 . . . . 0.0 112.88 -178.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -175.87 134.05 0.44 Allowed Pre-proline 0 N--CA 1.477 0.921 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -82.02 -170.41 0.95 Allowed 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 123.618 2.879 . . . . 0.0 109.473 154.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 94.9 mt -132.12 119.1 20.49 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.156 1.382 . . . . 0.0 108.287 164.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 93.8 mt -141.94 157.52 44.87 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.959 2.103 . . . . 0.0 108.224 -174.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 61.05 -126.1 39.72 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -163.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . 175.56 109.68 0.24 Allowed Glycine 0 CA--C 1.534 1.229 0 CA-C-O 118.561 -1.133 . . . . 0.0 112.926 174.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -76.68 149.93 30.59 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.957 2.438 . . . . 0.0 109.714 167.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 31.5 p90 -154.62 177.55 11.09 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 122.108 0.956 . . . . 0.0 113.102 -172.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 62.4 m -132.72 126.45 32.54 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 125.485 1.514 . . . . 0.0 108.132 157.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 1.2 mp -147.21 151.28 36.46 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.885 1.274 . . . . 0.0 112.145 173.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 80.4 m -89.02 139.54 30.35 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.341 1.457 . . . . 0.0 109.836 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' THR . . . . . . . . . . . . . 45.1 p -89.69 156.85 18.28 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 122.584 1.183 . . . . 0.0 111.911 178.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 6.6 p-80 -53.69 -25.83 20.08 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 127.291 2.236 . . . . 0.0 114.093 165.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 27.8 m -74.69 -46.08 40.14 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.626 1.571 . . . . 0.0 110.543 171.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 126.33 5.84 5.94 Favored Glycine 0 N--CA 1.476 1.355 0 C-N-CA 125.331 1.443 . . . . 0.0 115.885 175.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -99.09 155.73 17.3 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.056 1.342 . . . . 0.0 110.067 173.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -118.63 99.12 6.59 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 124.336 1.055 . . . . 0.0 111.318 -162.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.5 mmmt -93.27 166.77 12.15 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.499 1.12 . . . . 0.0 113.676 -169.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' THR . . . . . . . . . . . . . 32.8 p -112.25 -174.67 2.51 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 128.839 2.856 . . . . 0.0 108.364 164.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -70.99 -29.9 66.0 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 119.016 0.825 . . . . 0.0 111.086 165.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.78 -27.43 63.91 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.157 0.983 . . . . 0.0 113.524 -169.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -61.22 -33.71 73.93 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.095 0.958 . . . . 0.0 111.92 173.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -89.63 -1.25 57.96 Favored 'General case' 0 CA--C 1.545 0.774 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -176.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 6.7 tt -66.98 115.71 7.0 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.145 -0.972 . . . . 0.0 110.71 -175.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . 140.32 -10.81 3.01 Favored Glycine 0 N--CA 1.472 1.089 0 N-CA-C 115.053 0.781 . . . . 0.0 115.053 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.3 pm0 -127.0 167.86 15.33 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 118.306 1.053 . . . . 0.0 109.206 167.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -71.98 140.58 49.18 Favored 'General case' 0 CA--C 1.534 0.364 0 O-C-N 121.968 -0.457 . . . . 0.0 109.992 170.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 25.8 mt -122.97 135.96 54.68 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 123.96 0.904 . . . . 0.0 110.6 -178.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 84.1 mt -99.88 115.18 29.02 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 124.415 1.086 . . . . 0.0 108.143 166.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 40.6 mt -117.16 111.55 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -173.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -129.35 146.69 51.19 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.715 1.206 . . . . 0.0 112.049 -172.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -112.05 107.61 16.62 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 124.82 1.248 . . . . 0.0 110.259 -177.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -131.61 167.17 22.74 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 125.257 1.408 . . . . 0.0 115.291 -171.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -127.46 111.93 14.39 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.038 1.335 . . . . 0.0 110.041 -161.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 43.6 m -53.79 -30.51 45.1 Favored 'General case' 0 N--CA 1.483 1.183 0 O-C-N 121.148 -0.97 . . . . 0.0 113.085 -177.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -84.07 -2.15 56.17 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.922 1.689 . . . . 0.0 115.016 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -56.12 152.63 21.25 Favored Pre-proline 0 CA--C 1.547 0.853 0 CA-C-N 121.072 1.76 . . . . 0.0 113.205 175.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -78.49 -130.04 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.881 0 C-N-CA 123.627 2.885 . . . . 0.0 107.242 159.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -64.99 -18.87 65.65 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.583 1.553 . . . . 0.0 114.123 -174.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' VAL . . . . . . . . . . . . . 49.1 t -65.93 -65.12 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 124.64 1.176 . . . . 0.0 112.001 -160.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 1.7 m -52.49 -51.19 75.22 Favored Pre-proline 0 CA--C 1.545 0.785 0 CA-C-O 117.433 -1.27 . . . . 0.0 114.19 170.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -63.67 -24.9 69.12 Favored 'Trans proline' 0 C--N 1.352 0.747 0 CA-C-N 121.228 1.474 . . . . 0.0 114.24 -176.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 9.3 tm-20 -70.01 -33.76 72.44 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 120.573 1.533 . . . . 0.0 112.025 173.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.54 ' CD ' ' HZ3' ' A' ' 179' ' ' LYS . 73.0 mm-40 -76.23 -32.59 58.99 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 119.941 -1.724 . . . . 0.0 112.673 166.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.35 -41.01 98.82 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.855 1.262 . . . . 0.0 111.05 177.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -55.27 -55.98 25.19 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.721 1.608 . . . . 0.0 111.409 170.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.54 ' HZ3' ' CD ' ' A' ' 176' ' ' GLU . 32.9 mttp -53.02 -46.8 68.57 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.188 -0.945 . . . . 0.0 110.963 174.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' MET . . . . . . . . . . . . . 23.8 ttm -59.82 -44.8 93.85 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.044 1.337 . . . . 0.0 112.594 179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ILE . . . . . . . . . . . . . 11.6 mm -67.63 -51.61 49.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 119.744 1.156 . . . . 0.0 109.544 177.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLN . . . . . 0.494 ' HB3' ' HE3' ' A' ' 283' ' ' LYS . 65.7 mt-30 -66.06 -29.41 69.75 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-N 118.214 0.461 . . . . 0.0 111.425 -173.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 18.2 t -69.99 -37.49 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 124.178 0.991 . . . . 0.0 111.934 174.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . . . . . . . . . 68.0 t -69.04 -41.53 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 CA-C-N 119.784 1.175 . . . . 0.0 111.185 175.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -59.59 -46.96 87.41 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.04 0.936 . . . . 0.0 111.86 173.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -57.14 -43.17 82.19 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.502 1.521 . . . . 0.0 112.262 173.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 8.3 mm -72.57 -34.0 46.63 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 O-C-N 120.964 -1.085 . . . . 0.0 112.271 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 -68.17 -42.02 80.62 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.99 1.316 . . . . 0.0 111.476 170.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 10.7 t -64.59 -38.21 90.23 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.537 1.535 . . . . 0.0 110.984 176.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 8.0 mm -59.84 -19.13 16.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 O-C-N 120.491 -1.381 . . . . 0.0 112.647 167.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 98.2 m 74.17 -36.12 0.32 Allowed 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 128.15 2.58 . . . . 0.0 113.892 162.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' THR . . . . . . . . . . . . . 1.8 m -99.68 -17.8 17.59 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.202 1.801 . . . . 0.0 113.2 -155.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 11.0 mp -74.57 155.46 87.36 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 124.569 1.148 . . . . 0.0 109.436 166.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.65 -56.48 0.26 Allowed 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.023 1.815 . . . . 0.0 110.533 -168.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -174.32 158.2 2.88 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 128.778 2.831 . . . . 0.0 108.262 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' LEU . . . . . . . . . . . . . 20.6 tp -126.86 99.85 5.92 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.845 1.658 . . . . 0.0 108.993 167.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 1.7 m -89.07 119.6 69.81 Favored Pre-proline 0 N--CA 1.478 0.936 0 C-N-CA 123.65 0.78 . . . . 0.0 110.095 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -91.05 124.61 0.92 Allowed 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.395 2.73 . . . . 0.0 112.472 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 15.2 tp -117.44 94.4 4.54 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.499 1.92 . . . . 0.0 109.799 -171.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' PHE . . . . . . . . . . . . . 60.4 t80 -83.02 117.44 22.82 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.765 0.826 . . . . 0.0 109.676 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ILE . . . . . . . . . . . . . 97.5 mt -102.15 117.92 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.64 1.176 . . . . 0.0 109.439 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' SER . . . . . . . . . . . . . 35.8 t -74.65 128.87 36.61 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 174.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ILE . . . . . . . . . . . . . 21.0 pt -105.46 15.2 7.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.397 1.479 . . . . 0.0 113.366 169.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -110.66 39.73 0.16 Allowed Pre-proline 0 CA--C 1.559 1.303 0 C-N-CA 124.329 1.051 . . . . 0.0 113.464 -176.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -75.24 31.94 0.37 Allowed 'Trans proline' 0 C--N 1.36 1.159 0 C-N-CA 125.166 3.91 . . . . 0.0 113.532 -166.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -138.1 30.57 2.46 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.496 1.919 . . . . 0.0 110.446 -174.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 9.1 ptp85 168.39 -23.41 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 130.232 3.413 . . . . 0.0 112.16 -176.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -69.07 165.68 19.73 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 119.236 0.925 . . . . 0.0 112.206 175.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 8.9 m -153.79 135.25 14.25 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.916 0.886 . . . . 0.0 110.772 -176.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' LYS . . . . . . . . . . . . . 12.7 tmtt? -54.32 -47.41 72.51 Favored 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 125.508 1.523 . . . . 0.0 112.557 -177.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' GLU . . . . . . . . . . . . . 13.2 mp0 -70.72 -21.55 62.54 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 114.301 1.223 . . . . 0.0 114.301 173.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ALA . . . . . . . . . . . . . . . -74.86 -45.98 39.45 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-N 120.305 1.411 . . . . 0.0 111.176 173.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 28.0 mm -57.09 -36.86 52.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 123.758 0.823 . . . . 0.0 111.954 172.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ALA . . . . . . . . . . . . . . . -57.23 -32.95 67.05 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 174.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . . . . . . . . . 57.0 m-80 -77.11 -45.13 27.95 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.473 0.709 . . . . 0.0 111.466 172.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -52.67 -39.02 61.46 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 121.123 -0.986 . . . . 0.0 112.285 172.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 3.9 t -57.38 -65.86 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 C-N-CA 126.373 1.869 . . . . 0.0 111.664 169.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 7.7 mtmp? -55.08 -48.31 73.73 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 119.233 0.924 . . . . 0.0 112.886 -171.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.81 -26.81 62.55 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.029 1.332 . . . . 0.0 112.767 -170.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -84.38 -46.95 11.2 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.968 0.804 . . . . 0.0 111.696 166.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' SER . . . . . . . . . . . . . 13.4 t 174.67 132.46 0.13 Allowed Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 126.749 2.02 . . . . 0.0 109.971 166.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -66.47 -6.47 15.23 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.226 2.617 . . . . 0.0 114.539 -175.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' LYS . . . . . . . . . . . . . 76.2 tttt -73.44 -10.07 59.35 Favored 'General case' 0 CA--C 1.549 0.941 0 CA-C-N 119.692 1.133 . . . . 0.0 112.294 167.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 20.3 tp -68.01 129.34 39.63 Favored 'General case' 0 C--N 1.342 0.28 0 O-C-N 120.823 -1.173 . . . . 0.0 110.326 172.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 26.6 t -97.28 118.57 43.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 168.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' GLY . . . . . . . . . . . . . . . -100.86 124.07 8.13 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 179.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 4.4 mp -116.25 137.78 51.85 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.037 1.335 . . . . 0.0 110.636 -179.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 59.3 p -139.19 170.31 16.19 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 127.027 2.131 . . . . 0.0 108.901 177.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . . . . . . . . . . . -166.04 -174.59 35.65 Favored Glycine 0 CA--C 1.516 0.145 0 N-CA-C 111.412 -0.675 . . . . 0.0 111.412 169.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.9 t -67.49 162.94 22.12 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 160.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ARG . . . . . . . . . . . . . 23.4 ttm105 -44.11 -39.65 4.4 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.073 0.949 . . . . 0.0 112.995 175.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' GLU . . . . . . . . . . . . . 17.5 mp0 -68.56 -34.58 76.08 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.61 1.564 . . . . 0.0 111.977 -174.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -73.0 -37.08 67.12 Favored 'General case' 0 CA--C 1.544 0.748 0 O-C-N 120.85 -1.156 . . . . 0.0 111.177 172.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 85.0 t -67.2 -29.26 45.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 124.426 1.09 . . . . 0.0 112.472 172.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -65.77 -60.29 3.04 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 119.524 1.057 . . . . 0.0 108.604 163.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -46.37 -56.36 5.98 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 119.006 0.821 . . . . 0.0 112.584 -175.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' VAL . . . . . . . . . . . . . 8.9 p -73.85 -35.49 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 CA-C-N 119.5 1.046 . . . . 0.0 112.929 -172.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . . . . . . . . . . . -73.13 -30.66 63.77 Favored 'General case' 0 CA--C 1.533 0.323 0 O-C-N 121.538 -0.726 . . . . 0.0 112.201 178.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' ARG . . . . . . . . . . . . . 20.3 ttt180 -80.22 -36.98 33.98 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 126.552 1.941 . . . . 0.0 111.286 178.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -64.59 -52.48 57.36 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.073 0.949 . . . . 0.0 112.164 169.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -75.41 -5.97 47.66 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 175.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 54.72 53.55 10.41 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.429 1.892 . . . . 0.0 112.553 176.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 2.7 m -110.68 126.61 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 124.373 1.069 . . . . 0.0 111.182 -177.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -71.32 140.56 50.31 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 113.279 0.844 . . . . 0.0 113.279 -178.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -148.95 158.94 44.56 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.292 1.837 . . . . 0.0 110.55 160.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' SER . . . . . . . . . . . . . 16.3 t -149.37 122.22 4.41 Favored Pre-proline 0 CA--C 1.539 0.552 0 C-N-CA 123.958 0.903 . . . . 0.0 111.181 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -81.48 152.04 17.61 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.295 2.663 . . . . 0.0 111.729 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -83.67 -177.99 51.79 Favored Glycine 0 CA--C 1.538 1.507 0 C-N-CA 123.838 0.733 . . . . 0.0 112.014 164.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -78.85 -173.8 2.02 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.332 2.688 . . . . 0.0 110.395 172.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' LYS . . . . . 0.452 ' HZ3' ' CD ' ' A' ' 254' ' ' GLU . 6.6 mmpt? -66.78 126.56 29.4 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 154.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -150.05 158.72 44.45 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -170.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' GLU . . . . . . . . . . . . . 16.1 tt0 60.29 -42.93 0.1 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 131.275 3.83 . . . . 0.0 114.979 -171.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -165.6 -56.58 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 127.096 2.159 . . . . 0.0 109.964 175.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' GLU . . . . . 0.452 ' CD ' ' HZ3' ' A' ' 250' ' ' LYS . 23.0 tp10 -154.38 12.41 0.41 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 125.92 1.688 . . . . 0.0 112.029 -175.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -80.22 175.49 10.6 Favored 'General case' 0 CA--C 1.542 0.637 0 O-C-N 119.127 -2.233 . . . . 0.0 111.391 170.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -176.37 83.69 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.994 2.518 . . . . 0.0 106.781 -164.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' ILE . . . . . . . . . . . . . 8.7 tp -73.79 164.27 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 125.89 1.676 . . . . 0.0 111.039 -176.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 78.0 t -141.8 134.35 28.43 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 170.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -97.3 158.38 15.49 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.89 1.676 . . . . 0.0 110.261 166.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -162.9 144.66 10.14 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.597 1.159 . . . . 0.0 113.391 -166.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 6.4 t -65.8 -5.39 8.76 Favored 'General case' 0 N--CA 1.477 0.908 0 N-CA-C 116.615 2.08 . . . . 0.0 116.615 -172.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.838 ' O ' HG22 ' A' ' 262' ' ' ILE . 4.9 mt 34.81 73.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 126.624 1.97 . . . . 0.0 114.911 -172.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 91.7 mt -120.09 131.68 71.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 O-C-N 121.471 -0.768 . . . . 0.0 109.332 173.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' MET . . . . . . . . . . . . . 61.3 mtp -99.79 113.57 26.16 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.79 1.636 . . . . 0.0 108.138 156.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -79.5 138.27 37.49 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 120.461 -1.4 . . . . 0.0 110.27 166.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' LEU . . . . . . . . . . . . . 44.3 tp -95.43 112.31 24.04 Favored 'General case' 0 N--CA 1.465 0.318 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 168.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ILE . . . . . . . . . . . . . 1.7 mp -102.61 140.84 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 C-N-CA 124.158 0.983 . . . . 0.0 108.872 176.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -80.6 172.55 54.51 Favored Glycine 0 CA--C 1.541 1.663 0 C-N-CA 123.607 0.622 . . . . 0.0 113.412 176.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -70.1 66.4 1.97 Allowed 'Trans proline' 0 CA--C 1.541 0.834 1 C-N-CA 125.556 4.171 . . . . 0.0 110.416 168.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -173.47 -55.93 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.123 0.969 . . . . 0.0 110.322 -146.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 118.69 -26.48 7.6 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 117.905 -1.497 . . . . 0.0 114.614 178.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' GLU . . . . . . . . . . . . . 10.7 tt0 -97.19 163.14 13.04 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 119.909 1.854 . . . . 0.0 112.23 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -87.41 142.26 28.01 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 -173.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' LEU . . . . . . . . . . . . . 97.9 mt -126.92 -11.02 6.02 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.977 1.311 . . . . 0.0 113.923 -178.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -154.26 164.67 38.2 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.179 1.792 . . . . 0.0 109.141 169.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' TYR . . . . . . . . . . . . . 33.9 p90 -140.0 119.16 12.77 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.82 0.848 . . . . 0.0 109.265 167.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -96.34 121.25 37.94 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.315 -0.995 . . . . 0.0 108.315 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' GLY . . . . . . . . . . . . . . . -94.96 174.91 33.27 Favored Glycine 0 CA--C 1.529 0.967 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 163.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' GLN . . . . . 0.419 ' HB2' HG21 ' A' ' 262' ' ' ILE . 40.8 tt0 -65.49 78.24 0.07 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.423 1.489 . . . . 0.0 109.93 169.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -170.59 -44.7 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.881 1.272 . . . . 0.0 113.427 -170.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -66.47 120.24 13.03 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.897 0.771 . . . . 0.0 109.398 170.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -66.88 147.6 53.03 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 173.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . 0.494 ' HE3' ' HB3' ' A' ' 182' ' ' GLN . 12.9 tmtt? -39.32 -54.81 1.81 Allowed 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 -168.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' GLY . . . . . . . . . . . . . . . -67.18 -28.98 73.87 Favored Glycine 0 CA--C 1.535 1.332 0 CA-C-N 118.841 0.746 . . . . 0.0 114.177 -177.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -65.8 -25.47 67.25 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-N 118.706 1.253 . . . . 0.0 111.757 176.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 67.1 mt -66.95 -56.61 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.104 0.962 . . . . 0.0 109.649 176.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' ALA . . . . . . . . . . . . . . . -60.01 -34.8 73.85 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 123.777 0.831 . . . . 0.0 112.776 174.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -61.91 -36.29 80.9 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.709 0.803 . . . . 0.0 112.785 174.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.37 -46.37 88.96 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.074 0.852 . . . . 0.0 112.776 164.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' ILE . . . . . . . . . . . . . 58.2 mt -64.82 -39.15 84.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-N 120.06 1.3 . . . . 0.0 111.841 -176.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -65.96 -18.12 65.12 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.585 1.154 . . . . 0.0 113.978 173.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 93.9 m -85.28 -50.71 7.13 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.548 1.139 . . . . 0.0 110.335 174.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' HIS . . . . . . . . . . . . . 32.4 m-70 -67.35 -20.05 65.53 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.874 1.27 . . . . 0.0 113.028 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' MET . . . . . . . . . . . . . 13.1 tmm? -58.26 -29.69 65.98 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.288 1.035 . . . . 0.0 113.001 165.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -54.65 -48.8 94.33 Favored Pre-proline 0 CA--C 1.547 0.846 0 CA-C-N 120.566 1.53 . . . . 0.0 112.664 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -74.65 -54.01 0.1 OUTLIER 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 122.619 2.213 . . . . 0.0 112.268 167.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' TYR . . . . . . . . . . . . . 5.3 m-30 -94.98 73.66 3.47 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-O 123.67 1.7 . . . . 0.0 111.215 -171.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' ARG . . . . . . . . . . . . . 47.7 ptt85 -90.55 123.36 34.15 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 117.004 2.224 . . . . 0.0 117.004 -153.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' LYS . . . . . 0.444 ' HG2' ' H ' ' A' ' 300' ' ' LYS . 11.7 ttpp 71.95 -141.84 0.05 OUTLIER 'General case' 0 CA--C 1.552 1.044 0 CA-C-N 113.734 -1.575 . . . . 0.0 114.386 126.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' LYS . . . . . 0.444 ' H ' ' HG2' ' A' ' 299' ' ' LYS . 23.5 mttt -145.73 34.09 1.03 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 129.076 2.95 . . . . 0.0 107.898 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' SER . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.487 1.404 0 C-N-CA 130.388 3.475 . . . . 0.0 111.112 -161.906 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_